4.7 Article

Evaluation of Various Empirical Formulas for Estimating Mean Pulmonary Artery Pressure by Using Systolic Pulmonary Artery Pressure in Adults

Journal

CHEST
Volume 135, Issue 3, Pages 760-768

Publisher

ELSEVIER
DOI: 10.1378/chest.08-0904

Keywords

hemodynamics; pulmonary circulation; pulmonary hypertension

Ask authors/readers for more resources

Background: Mean pulmonary artery pressure (mPAP) may be estimated by using the classic rule of thumb, namely 2/3 x dPAP + 1/3 x sPAP, where dPAP = diastolic PAP and sPAP = systolic PAP. Studies have suggested that mPAP may be also estimated from sPAP alone. Pulmonary hypertension (PH) is usually defined by an invasive mPAP > 25 mm Hg, but the corresponding sPAP threshold remains to be established. Our study evaluated the accuracy and precision of various empirical formulas relating mPAP and sPA-P in resting adults. Methods: Five previously published studies with individual high-fidelity, PAPs were analyzed (n = 166 individuals, 57% of whom had PH). The time-averaged mPAP was compared with formula one (F1), the classic rule of thumb; formula two (F2) = dPAP + 0.41 X pulse PAP; formula three (F3) = square root of (sPAP x dPAP); formula four (F4) = 0.61 x sPAIV + 2 mm Hg; and formula five (F5) = 2/3 x sPAP (parabolic shape). Results: The mPAP ranged from 9 to 82 mm Hg and was related to sPAP (r(2) = 0.98). The most accurate formula was F4 (mean bias, 0.0 mm Hg). The most precise formula was F1 (SD of the bias, 1.6 mm Hg). Other formulas gave estimates of essentially similar accuracy, while F2 and F3 were more precise than F4 and F5. sPAP > 36 min Hg could be used to diagnose PH (mPAP > 25 mm Hg) with a 97.9% sensitivity and 98.6% specificity. Conclusion: In resting adults, the most accurate estimate of mPAP was obtained by using sPAP only, while the combination of sPAP and dPAP gave the most precise mPAP estimate. The sPAP threshold of 36 mm Hg could be used to diagnose PH with high sensitivity and high specificity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

Knowledge exchange between patient and pharmacist: A mixed methods study to explore the role of pharmacists in patient education and counseling in asthma and pulmonary arterial hypertension

S. Renet, M. -C. Chaumais, M. Gallant-Dewavrin, E. Jouet, Y. Bezie, M. Humbert, A. Rieutord, O. Las Vergnas

Summary: This study aimed to explore the role of pharmacists in patient education and counseling, describing the perception of knowledge exchange (KE) between asthma/pulmonary arterial hypertension patients and pharmacists (hospital/community) based on the 4C typology: cure (C1), care (C2), coordination/supply chain (C3), and characteristics of the pathophysiology/disease mechanisms (C4). The results showed that KE was correlated with pathology, disease severity, disease duration, age, and hospital/community pharmacist. Patients expected pharmacists to provide care and coordination/supply chain services. The 4C typology provides a holistic framework for optimizing the pharmacists' role in education and counseling of patients with chronic diseases.

ANNALES PHARMACEUTIQUES FRANCAISES (2023)

Review Critical Care Medicine

Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting Best Practice

Bartolome R. Celli, Leonardo M. Fabbri, Shawn D. Aaron, Alvar Agusti, Robert D. Brook, Gerard J. Criner, Frits M. E. Franssen, Marc Humbert, John R. Hurst, Maria Montes de Oca, Leonardo Pantoni, Alberto Papi, Roberto Rodriguez-Roisin, Sanjay Sethi, Daiana Stolz, Antoni Torres, Claus F. Vogelmeier, Jadwiga A. Wedzicha

Summary: Patients with chronic obstructive pulmonary disease (COPD) may experience acute episodes of worsening dyspnea, accompanied by increased cough, sputum, and/or sputum purulence. These exacerbations impact health status, accelerate lung function decline, and increase the risk of hospitalization. It is important to recognize and address other morbidities that can mimic or aggravate COPD exacerbations to improve outcomes and reduce readmissions.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Rheumatology

Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis

Sebastien Sanges, Lisa Rice, Ly Tu, Eleanor Valenzi, Jean-Luc Cracowski, David Montani, Julio C. Mantero, Camille Ternynck, Guillemette Marot, Andreea M. Bujor, Eric Hachulla, David Launay, Marc Humbert, Christophe Guignabert, Robert Lafyatis

Summary: This study examined the serum proteome of patients with systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) and identified two proteins that were significantly correlated with pulmonary vascular resistance (PVR), potentially providing biomarkers for earlier diagnosis and treatment.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Review Medicine, General & Internal

Definitions and classification of pulmonary hypertension: An update

D. Montani, E-M Jutant, G. Simonneau, M. Humbert

Summary: The 2022 guidelines from the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) propose a new definition of pulmonary hypertension (PH) based on hemodynamics, lowering the threshold of mean pulmonary arterial pressure (mPAP) to 20 mmHg. They also introduce a new clinical classification of PH, integrating new data from the literature and dividing it into five groups based on distinct mechanisms.

BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE (2023)

Letter Medicine, General & Internal

Pathophysiology and treatment of pulmonary hypertension

M. Humbert

BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE (2023)

Review Respiratory System

Lung transplantation for severe pulmonary hypertension

J. Le Pavec, L. Savale, G. Prevot, D. Montani, O. Sitbon, E. Fadel, M. Humbert, O. Mercier

REVUE DES MALADIES RESPIRATOIRES (2023)

Article Rheumatology

In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicentre study

Benjamin Chaigne, Kevin Chevalier, Athenais Boucly, Christian Agard, Antoine Baudet, Arnaud Bourdin, Celine Chabanne, Vincent Cottin, Pierre Fesler, Francois Goupil, Patrick Jego, David Launay, Herve Levesque, Arnaud Maurac, Shirine Mohamed, Cecile Tromeur, Laurence Rottat, Olivier Sitbon, Marc Humbert, Luc Mouthon

Summary: Objective of this study was to describe PAH in well-characterized MCTD patients. Results showed that pericarditis, polyarthritis, thrombocytopenia, ILD and anti-Sm antibodies were independent predictive factors of PAH in MCTD. Survival rates of MCTD-PAH patients did not differ from SLE-PAH and SSc-PAH patients. Tobacco exposure was an independent predictor of mortality in MCTD-PAH.

RHEUMATOLOGY (2023)

Article Medicine, Research & Experimental

Physiopathology and treatment of pulmonary arterial hypertension

Frederic Perros, Etienne-Marie Jutant, Laurent Savale, Peter Dorfmueller, Marc Humbert, David Montani

Summary: Pulmonary arterial hypertension (PAH) is a rare disease that mainly affects the pre-capillary pulmonary vascular bed, but some forms of the disease involve venous/capillary involvement. It is characterized by obstructive remodeling of the pulmonary arterioles, vascular pruning, increased right ventricular afterload, and right heart failure. Current treatments focus on targeting endothelial dysfunction and vasodilation, while new treatments aiming at pulmonary artery remodeling are being developed.

M S-MEDECINE SCIENCES (2023)

Article Cell Biology

Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in Rats

Matthieu Leuillier, Valentin Platel, Ly Tu, Guillaume Feugray, Raphael Thuillet, Deborah Groussard, Hind Messaoudi, Mina Ottaviani, Mustapha Chelgham, Lionel Nicol, Paul Mulder, Marc Humbert, Vincent Richard, Christophe Morisseau, Valery Brunel, Thomas Duflot, Christophe Guignabert, Jeremy Bellien

Summary: Inhibitors of soluble epoxide hydrolase (sEH) present an opportunity for developing oral drugs for cardiovascular and inflammatory diseases. However, the administration of sEH inhibitors may lead to the development of pulmonary hypertension (PH). This study evaluated the impact of chronic oral administration of the sEH inhibitor TPPU on hemodynamics and pulmonary vascular remodeling in rats. The results showed that TPPU did not induce or aggravate PH and RV dysfunction, and may have a potential beneficial effect against pulmonary artery remodeling in humans.

CELLS (2023)

Editorial Material Respiratory System

The flare of care for rare: per aspera ad astra for rare lung diseases!

Marlies Wijsenbeek, Marc Humbert, Thomas Wagner, Michael Kreuter

EUROPEAN RESPIRATORY REVIEW (2023)

Article Respiratory System

2022 Update of indications and contraindications for lung transplantation in France

Jerome Le Pavec, Christophe Pison, Sandrine Hirschi, Vincent Bunel, Pierre Mordant, Olivier Brugiere, Morgan Le Guen, Anne Olland, Benjamin Coiffard, Benjamin Renaud-Picard, Adrien Tissot, Geoffrey Brioude, Raphael Borie, Bruno Crestani, Gaetan Deslee, Sandrine Stelianides, Herve Mal, Armelle Schuller, Loic Falque, Gwenaelle Lorillon, Abdellatif Tazi, Pierre Regis Burgel, Dominique Grenet, Sandra De Miranda, Anne Bergeron, David Launay, Vincent Cottin, Hilario Nunes, Dominique Valeyre, Yurdagul Uzunhan, Gregoire Prevot, Olivier Sitbon, David Montani, Laurent Savale, Marc Humbert, Elie Fadel, Olaf Mercier, Jean Francois Mornex, Gaelle Dauriat, Martine Reynaud-Gaubert

Summary: Lung transplantation is a rapidly evolving field that has made significant advancements in improving donor and recipient selection, addressing surgical challenges, perioperative care, and long-term complications. To assist pulmonologists in managing end-stage respiratory insufficiency, determining eligibility for lung transplantation, and referring patients to transplant centers, the Francophone Pulmonology Society has established a task force to develop comprehensive guidelines based on the latest literature and evaluation of risk factors for patient survival after transplantation.

RESPIRATORY MEDICINE AND RESEARCH (2023)

Article Respiratory System

Functional respiratory complaints among COVID-19 survivors: a prospective cohort study

Antoine Beurnier, Laurent Savale, Xavier Jais, Romain Colle, Tai Pham, Luc Morin, Sophie Bulifon, Nicolas Noel, Athenais Boucly, Benoit Delbarre, Nathan Ebstein, Samy Figueiredo, Matthieu Gasnier, Anatole Harrois, Etienne-Marie Jutant, Mitja Jevnikar, Sophia Keddache, Anne-Lise Lecoq, Olivier Meyrignac, Florence Parent, Jeremie Pichon, Mariana Preda, Anne Roche, Andrei Seferian, Marie-France Bellin, Thomas Gille, Emmanuelle Corruble, Olivier Sitbon, Laurent Becquemont, Xavier Monnet, Marc Humbert, David Montani

Summary: This study found that functional respiratory complaints are common in post-COVID-19 individuals, especially among those with unexplained dyspnoea. These complaints are associated with the severity of dyspnoea, quality of life, and psychological symptoms.

ERJ OPEN RESEARCH (2023)

Letter Critical Care Medicine

Effect of COVID-19 in Pulmonary Hypertension Reply

David Montani, Jason Weatherald, Marc Humbert, Olivier Sitbon

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Correction Cardiac & Cardiovascular Systems

HFp2EF: heart failure with pulmonary dysfunction and preserved ejection fraction? (vol 43, pg 2209, 2022)

Bradley M. Maron, Marc Humbert

EUROPEAN HEART JOURNAL (2023)

No Data Available